Titleist Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$281K Sell
2,186
-180
-8% -$21.1K 0.02% 361
2026
Q1
$285K Buy
+2,366
New +$273K 0.02% 335
2025
Q2
Sell
-4,510
Closed -$405K 328
2025
Q1
$405K Buy
4,510
+312
+7% +$29.1K 0.05% 212
2024
Q4
$418K Buy
4,198
+441
+12% +$45.5K 0.05% 213
2024
Q3
$427K Buy
3,757
+26
+0.7% +$3.09K 0.06% 188
2024
Q2
$462K Buy
3,731
+237
+7% +$30.5K 0.07% 173
2024
Q1
$461K Buy
3,494
+522
+18% +$64.3K 0.08% 161
2023
Q4
$324K Buy
2,972
+238
+9% +$24.7K 0.06% 173
2023
Q3
$281K Buy
2,734
+5
+0.2% +$539 0.06% 174
2023
Q2
$315K Sell
2,729
-101
-4% -$11.5K 0.06% 173
2023
Q1
$301K Buy
+2,830
New +$306K 0.06% 167

Other funds holding MRK

Titleist Asset Management's MRK Position: Q2 2026 in Review

Titleist Asset Management reduced its Merck (MRK) stake by 7.6% in Q2 2026, selling an estimated $21.1K and leaving 2,186 shares worth $281K. The position accounts for 0.02% of the portfolio, ranked #361.

Titleist Asset Management first reported a position in MRK in Q1 2023 and has held it in 11 quarters since. The position peaked at $462K in Q2 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Titleist Asset Management held 2,186 shares of Merck worth $281K as of Q2 2026.
  • Titleist Asset Management sold 180 Merck shares in Q2 2026, an estimated $21.1K.
  • Merck made up 0.02% of Titleist Asset Management's portfolio in Q2 2026, its #361 holding.
  • Titleist Asset Management first reported a position in Merck in Q1 2023 and has held it in 11 quarters since.
  • Titleist Asset Management's Merck position peaked at $462K in Q2 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Titleist Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.